Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826.
Article PubMed CAS Google Scholar
Stone E. An account of the success of the bark of the willow tree in the cure of agues. Philos Trans R Soc Lond B Biol Sci. 1763;53:195.
Weiss HJ, Aledort LM. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet. 1967;2:495–7.
Article PubMed CAS Google Scholar
Awtry EH, Loscalzo J. Aspirin. Circulation. 2000;101(10):1206–18.
Article PubMed CAS Google Scholar
McNeil JJ, Wolfe R, Woods RL, Tonkin AM, Donnan GA, Nelson MR, et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly. N Engl J Med. 2018;379(16):1509–18.
Article PubMed PubMed Central CAS Google Scholar
Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised double-blind placebo controlled trial. Lancet. 2018;392(10152):1036–46.
Article PubMed PubMed Central CAS Google Scholar
Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G, Barton J, et al. Effects of aspirin in primary prevention in persons with diabetes mellitus. N Engl J Med. 2018;379(16):1529–39.
Article PubMed CAS Google Scholar
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Antithrombotic Trialists’ (ATT) Collaboration, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–60.
ISIS‑2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS‑2. Lancet. 1988;2(8607):349–60.
ACC/AHA Task Force. ACC/AHA task force report. Guidelines for the early management of patients with acute myocardial infarction. J Am Coll Cardiol. 1990;16:249–92.
Tataris K, Mercer MP, Govindarajan P. Prehospital aspirin administration for acute coronary syndrome (ACS) in the USA: an EMS quality assessment using the NEMSIS 2011 database. Emerg Med J. 2015;32(11):876–81.
Gurbel PA, Bliden KP, Kundan P, Kraft D, Parekh R, Singh S, et al. Early assessment of the pharmakokinetic and pharmkodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response. J Thromb Thrombolysis. 2024;57(1):21–8.
Article PubMed CAS Google Scholar
Santos RC, Goulart AC, Kisukuri AL, Brandão RM, Sitnik D, Staniak HL. Time-to-treatment of acute coronary syndrome and unit of first contact in the ERICO study. Arq Bras Cardiol. 2016;107(4):323–30.
PubMed PubMed Central Google Scholar
Freimark D, Metetzky S, Leor J, Boyko V, Barbash IM, Behar S. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol. 2002;89(4):381–5.
Article PubMed CAS Google Scholar
Djarv T, Swain JM, Chang WT, Zideman DA, Singletary E. Early or first aid administration versus late or in-hospital administration of aspirin for non-traumatic adult chest pain: a systematic review. Cureus. 2020;12(2).
Nordt SP, Clark RF, Castillo EM, Guss DA. Comparison of three aspirin formulations in human volunteers. West J Emerg Med. 2011;12(4):381–5.
Article PubMed PubMed Central Google Scholar
Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L, et al. Randomized open-label crossover trial comparing the pharmakokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet. Int J Clin Pharmacol Ther. 2022;60(10):430–8.
Article PubMed PubMed Central CAS Google Scholar
Kaur H, Sarma P, Bhattacharyya A, Rohit M, Prajapat M, Kumar S, et al. Role of intravenous versus oral aspirin in the treatment of acute coronary syndrome: answering a clinical query by systematic review and meta-analysis of randomized controlled trials. Indian J Pharmacol. 2023;55(2):133–7.
Article PubMed PubMed Central CAS Google Scholar
Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation. 2006;114:774–82.
Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, HORIZONS-AMI Trial Investigators, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218–30.
Article PubMed CAS Google Scholar
Valgimigli M, Gagnor A, Calabro P, Frigoli E, Leonardi S, Zaro T, MATRIX Investigators, et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465–76.
Simonsson M, Wallentin L, Alfredsson J, Erlinge D, Ängerud KH, Hofman R, et al. Temporal trends in bleeding events in acute myocardial infarction: insights from the SWEDEHEART registry. Eur Heart J. 2020;41(7):833–43.
Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/ SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. J Cardiovasc Comput Tomogr. 2022;16(1):54–122.
Hoorweg BB, Willemsen RT, Cleef LE, Boogaerts T, Buntinx F, Glatz JF. Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses. Heart. 2017;103:1727–32.
Schillinger M, Sodeck G, Meron G, Janata K, Nikfardjam M, Rauscha F, et al. Acute chest pain—identification of patients at low risk for coronary events. The impact of symptoms, medical history and risk factors. Wien Klin Wochenschr. 2004;116:116–89.
Mahajan S, Valero-Elizondo J, Khera R, Desai NR, Blankstein R, Blaha MJ, et al. Variation and disparities in awareness of myocardial infarction symptoms among adults in the United States. JAMA Netw Open. 2019;2:e1917885.
Article PubMed PubMed Central Google Scholar
Patel A, Fang J, Gillespie C, Odom E, Luncheon C, Ayala C. Awareness of heart attack signs and symptoms and calling 9‑1‑1 among US adults. J Am Coll Cardiol. 2018;71(7):808–9.
Article PubMed PubMed Central Google Scholar
Birnbach B, Höpner J, Mikolajczyk R. Cardiac symptom attribution and knowledge of the symptoms of acute myocardial infarction: a systematic review. BMC Cardiovasc Disord. 2020;20:445.
Article PubMed PubMed Central Google Scholar
Sharma A, Vidusha K, Suresh H, et al. Global awareness of myocardial infarction symptoms in general population: a systematic review and meta-analysis. Korean Circ J. 2021;51:983–96.
Article PubMed PubMed Central Google Scholar
Cannesson M, Burckard E, Lefevre M, Bastien O, Lehot JL. Predictors of in-hospital mortality in the surgical management of acute type a aortic dissections: impact of anticoagulant therapies. Ann Fr Anesth Reanim. 2004;23(6):568–74.
Article PubMed CAS Google Scholar
Jiang X, Khan F, Shi E, Fan R, Qian X, Zhang H, et al. Outcomes of preoperative antiplatelet therapy in patients with acute type A aortic dissection. J Card Surg. 2022;37(1):53–61.
Elwood PC, Morgan G, Galante J, et al. Systematic review and meta-analysis of randomised trials to ascertain fatal gastrointestinal bleeding events attributable to preventive low-dose aspirin: no evidence of increased risk. Plos One. 2016;11:e166166.
Article PubMed PubMed Central Google Scholar
Quan D, LoVecchio F, Gallagher JV. Prehospital use of aspirin rarely is associated with adverse events. Prehosp Disaster Med. 2004;19(4):362–5.
留言 (0)